Viking global investing in a theme here, or are they propping up the company as a scorpion is kind of alleging they are doing so. synthetic biology might be such an emerging technology that these companies shouldn't go public. And this is the sort of achilles heel, i think, of the entire movement of spacks. Companies that are nascent need time to figure out their business model, not be under scrutiny.